Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season

The summary for the Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.

Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season: The purpose of this FOA is to provide support for research to determine the effectiveness of empiric influenza antiviral therapy, in addition to standard care, for hospitalized patients with lower respiratory tract illness (LRTI) during the periods when influenza viruses are circulating in the community.

Federal Grant Title:	Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia during the Influenza Season
Federal Agency Name:	Centers for Disease Control and Prevention
Grant Categories:	Health
Type of Opportunity:	Discretionary
Funding Opportunity Number:	RFA-IP-14-001
Type of Funding:	Cooperative Agreement
CFDA Numbers:	93.083
CFDA Descriptions:	Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases
Current Application Deadline:	Dec 9, 2013 Application Due Date: December 9, 201
Original Application Deadline:	Dec 9, 2013 Application Due Date: December 9, 201
Posted Date:	Oct 31, 2013
Creation Date:	Oct 31, 2013
Archive Date:	Jan 8, 2014
Total Program Funding:	$200,000
Maximum Federal Grant Award:	$200,000
Minimum Federal Grant Award:	$150,000
Expected Number of Awards:	1
Cost Sharing or Matching:	No

Applicants Eligible for this Grant: Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility: Eligible Applicants/Organizations:

Dr. Julio Ramirez, University of Louisville, Division of Infectious Diseases, 501 E Broadway, Suite 380, Louisville, KY 40202
Grant Announcement Contact: CDC Procurement and Grants Office (PGO) Technical Information Management Section (TIMS) Phone: 770-488-2700
TECHNICAL INFORMATION MANAGEMENT SECTION (TIMS)

Centers for Disease Control and Prevention 404-498-2015
Similar Government Grants: • Collaborative research on influenza and other respiratory pathogens in South Africa; • Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...; • Nationwide Cohort to Estimate Burden of Respiratory Viruses and Immunologic Response (Bloo...; • Network of Community Cohorts for Monitoring Changes in Respiratory Virus Epidemiology (Pan...; • Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infections in a...; • Economic Studies of Immunization Policies and Practices; • US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influe...
More Grants from the Centers for Disease Control and Prevention: • Advancing Diagnostic Network Optimization, Stepwise Laboratory Accreditation, and Integrat...; • Strengthening Public Health Systems and Services through National Partnerships to Improve ...; • 93.067; • Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...; • Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...